Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease

被引：0
|
作者：
Volkers, A. [1 ]
Straatmijer, T. [1 ]
Duijvestein, M. [2 ]
Sales, A. [1 ]
Levran, A. [1 ]
van Schaik, F. [3 ]
Jeroen, M. [4 ]
Gecse, K. [1 ]
Ponsioen, C. [1 ]
Grootjans, J. [1 ]
Hanzel, J. [1 ]
Tack, G. [5 ]
Jansen, J. [6 ]
Hoentjen, F. [7 ]
de Boer, N. [1 ]
van der Marel, S. [8 ]
Dijkstra, G. [9 ]
Oldenburg, B. [3 ]
Lowenberg, M. [1 ]
van der Meulen, A. [4 ]
D'Haens, G. [1 ]
机构：
[1] Amsterdam UMC, Locat AMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
[3] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[4] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[5] Med Ctr Leeuwarden, Dept Gastroenterol & Hepatol, Leeuwarden, Netherlands
[6] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[7] Univ Alberta, Dept Med, Div Gastroenterol, Edmonton, AB, Canada
[8] Haaglanden Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[9] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP63
引用
收藏
页码：I108 / I109
页数：3
相关论文
共 50 条
  • [1] SWITCHING INTRAVENOUS VEDOLIZUMAB MAINTENANCE TREATMENT TO SUBCUTANEOUS VEDOLIZUMAB TREATMENT FOR INFLAMMATORY BOWEL DISEASE
    Volkers, Adriaan
    Straatmijer, Tessa
    Duijvestein, Marjolijn
    Sales, Amber
    Levran, Amit
    Van Schaik, Fiona
    Maljaars, Jeroen
    Gecse, Krisztina B.
    Ponsioen, Cyriel Y.
    Grootjans, Joep
    Hanzel, Jurij
    Tack, Greetje
    Jansen, Jeroen M.
    Hoentjen, Frank
    De Boer, Nanne
    van der Marel, Sander
    Dijkstra, Gerard
    Oldenburg, Bas
    Lowenberg, Mark
    Meulen-De Jong, Andrea V.
    D'Haens, Geert
    GASTROENTEROLOGY, 2022, 162 (07) : S820 - S821
  • [2] Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
    Volkers, Adriaan
    Straatmijer, Tessa
    Duijvestein, Marjolijn
    Sales, Amber
    Levran, Amit
    van Schaik, Fiona
    Maljaars, Jeroen
    Gecse, Krisztina
    Ponsioen, Cyriel
    Grootjans, Joep
    Hanzel, Jurij
    Tack, Greetje
    Jansen, Jeroen
    Hoentjen, Frank
    de Boer, Nanne
    van der Marel, Sander
    Dijkstra, Gerard
    Oldenburg, Bas
    Lowenberg, Mark
    van der Meulen, Andrea
    D'Haens, Geert
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (06) : 1044 - 1054
  • [3] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
  • [4] Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
    Bergqvist, Viktoria
    Holmgren, Johanna
    Klintman, Daniel
    Marsal, Jan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) : 1389 - 1401
  • [5] Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience
    Kopylov, Uri
    Avni-Biron, Irit
    Ron, Yulia
    Koslowsky, Benjamin
    Waterman, Matti
    Daher, Saleh
    Ungar, Bella
    Schwartz, Doron
    Zittan, Eran
    Openhaim, Michal
    Yanai, Henit
    Maharshak, Nitsan
    Shitrit, Ariella Bar Gil
    Naftali, Timna
    Eliakim, Rami
    Chowers, Yehuda
    Ben-Horin, Shomron
    Dotan, Iris
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (01) : 68 - 74
  • [6] Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease
    Kolehmainen, Sara
    Rautakorpi, Jaakko
    Loyttyniemi, Eliisa
    Af Bjorkesten, Clas-Goeran
    Arkkila, Perttu
    Salminen, Kimmo
    Sipponen, Taina
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (10) : 1193 - 1201
  • [7] Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission
    Parisio, Laura
    Settanni, Carlo Romano
    Varca, Simone
    Laterza, Lucrezia
    Lopetuso, Loris Riccardo
    Napolitano, Daniele
    Schiavoni, Elisa
    Turchini, Laura
    Fanali, Caterina
    Alfieri, Norma
    Pizzoferrato, Marco
    Papa, Alfredo
    Pafundi, Pia Clara
    Armuzzi, Alessandro
    Gasbarrini, Antonio
    Pugliese, Daniela
    Scaldaferri, Franco
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2023, 32 (04) : 452 - 459
  • [8] Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring
    Wiken, Thea H.
    Hoivik, Marte L.
    Buer, Lydia
    Warren, David J.
    Bolstad, Nils
    Moum, Bjorn A.
    Anisdahl, Karoline
    Smastuen, Milada C.
    Medhus, Asle W.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, : 863 - 873
  • [9] Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
    Lamichhane, N.
    Melas, N.
    Bergqvist, V.
    Ekholm, N. -P.
    Olen, O.
    Ludvigsson, J. F.
    Hjortswang, H.
    Marsal, J.
    Eriksson, C.
    Halfvarson, J.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (06) : 2175 - 2183
  • [10] Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry
    Louis, E.
    Muls, V.
    Bossuyt, P.
    Colard, A.
    Nakad, A.
    Baert, D.
    Mana, F.
    Caenepeel, P.
    Vanden Branden, S.
    Vermeire, S.
    D'Heygere, F.
    Strubbe, B.
    Cremer, A.
    Coche, J. -C.
    Setakhr, V.
    Baert, F.
    Vijverman, A.
    Coenegrachts, J. L.
    Flamme, F.
    Hantson, A.
    Wijnen, K.
    Piters, E.
    Hantsbarger, G.
    Wan, F.
    Jiang, B.
    Dolin, P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S153 - S154
12345